By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a



Drug Delivery

Company News
Novavax, Inc. (NVAX) To Present RSV Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26 10/24/2014 10:35:10 AM
Novavax, Inc. (NVAX) Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies 10/15/2014 8:00:49 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV Vaccine In Elderly Subjects 10/14/2014 8:03:36 AM
Novavax, Inc. (NVAX) Announces Biomedical Advanced Research and Development Authority (BARDA) Exercise Of Contract Option 9/23/2014 8:25:00 AM
Novavax, Inc. (NVAX)' H7n9 Avian Influenza VLP Vaccine Candidate With Matrix-M™ Delivers Positive Phase 1/2 Clinical Data 9/23/2014 8:21:47 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV F-Protein Nanoparticle Vaccine Candidate In Healthy Third-Trimester Pregnant Women 9/17/2014 7:34:27 AM
Novavax, Inc. (NVAX) To Host 2nd Annual Analyst And Investor Meeting 9/12/2014 10:32:46 AM
Novavax, Inc. (NVAX) Release: ICAAC Presentation: Immunization Of Pregnant Baboons With The RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus In A Comparable Manner To Infants Prophylaxed With Palivizumab 9/8/2014 10:13:40 AM
Novavax, Inc. (NVAX) Presents Data On RSV F Nanoparticle Vaccine Induced Monoclonal Antibody At ICAAC 9/8/2014 7:36:43 AM
Novavax, Inc. (NVAX) To Present RSV Vaccine Preclinical Results At ICAAC 9/4/2014 8:55:24 AM